Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09AYM
|
|||
| Drug Name |
MABp1
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 3 | [1] | |
| Acne vulgaris [ICD-11: ED80; ICD-10: L70.0; ICD-9: 706.1] | Phase 2 | [2] | ||
| Atopic dermatitis [ICD-11: EA80; ICD-10: L20; ICD-9: 691.8, 692.9] | Phase 2 | [2] | ||
| Hidradenitis suppurativa [ICD-11: ED92.0; ICD-10: L73.2] | Phase 2 | [2] | ||
| Peripheral vascular disease [ICD-11: BD4Z; ICD-10: I73.9; ICD-9: 443.9] | Phase 2 | [3] | ||
| Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0] | Phase 2 | [2], [4] | ||
| Pyoderma gangrenosum [ICD-11: EB21] | Phase 2 | [2] | ||
| Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 2 | [5] | ||
| Company |
Xbiotech Austin, TX
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 5 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.